{"name":"Oneness Biotech Co., Ltd.","slug":"oneness-biotech-co-ltd","ticker":"","exchange":"","domain":"oneness.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"FB825","genericName":"FB825","slug":"fb825","indication":"Type 2 diabetes","status":"phase_2"},{"name":"ON101 Cream","genericName":"ON101 Cream","slug":"on101-cream","indication":"Chronic diabetic foot ulcers","status":"marketed"}]}],"pipeline":[{"name":"FB825","genericName":"FB825","slug":"fb825","phase":"phase_2","mechanism":"FB825 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"ON101 Cream","genericName":"ON101 Cream","slug":"on101-cream","phase":"marketed","mechanism":"ON101 Cream is a topical formulation that promotes wound healing and tissue repair through growth factor signaling and anti-inflammatory mechanisms.","indications":["Chronic diabetic foot ulcers","Pressure ulcers / decubitus ulcers"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTXMzalVsd0VQa0V6cGxWTDFvZEpMRHVrMXB4eUhlS001eUpMN1hGSUpRZ25RVUlHX2FfSUxFZnV4UkZNR0N4RGRuckJWTkNHcXJ3dEs4Zy1uRm41bVQyNlE1NEgxNS00OFB4eWNnTlVIQ01NYjBCaERJUzgtVXhZWWxzQThiTkFsLS1Ibjg4dEtydW81THg0U0l2b29pNEZvc3UyMk9fOHJjQQ?oc=5","date":"2026-04-07","type":"trial","source":"Yahoo Finance","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight - Yahoo Finance","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPVnZGYTBfR3o4czAtRFJXU1dwX190aXBvd3dCVUhxUnZXekRSeDR1TmN4ZkpHZWhVSlVBcWNVNXlXYmVQamUzWm9UR0hfY0pkaDNzV0NPdGV1aXFDREEzTGZTOUk0aEppbk9GUGs5b3R6MGdOOHR4djRLTkh2OW1Ub2t0dGh6SUV5VEctOFpOTzRHb05OSmRSVUQzRjhOOEZpZ3hfQ1hONzk0dm9xeEZqeTczSFBoWjllakRONGEzRzI1RDAxMlF6NmM3b0JYajJBWG1oU3dPczFZTkt6a3ZFeU5ER1pkZ0t6S21KVnUzVjhfRV9qRGJNb01HNkVUSVNIV0pmdEU4YU9fcGJBWmU0?oc=5","date":"2026-02-16","type":"pipeline","source":"PR Newswire","summary":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - PR Newswire","headline":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"GlobeNewswire","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - GlobeNewswire","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNb1oxRnMxclhVZTJDZW1jYV9yUGQzS3czVVJWdTltall3bFhzSm1RSjF1cEtDd2xSYmg2Nm1xaFR2SFpkYm1uUDBEdEF3NGhjcTIycXY1aExRcEw0VEoyeXZxTnBqakVQbmNEeG9kdldxQ3Y3cjVKQmRtY1A4d05XNGg4dnpCcTBNY3VUOFVuTjZrdw?oc=5","date":"2025-07-01","type":"pipeline","source":"BioSpectrum Asia","summary":"Taiwan's biotech gathers momentum - BioSpectrum Asia","headline":"Taiwan's biotech gathers momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQUlBEN2JQMkVlejVsUDE0d0pQcXhDTHBHdE1nMmhzTVNERFBfTDkzWW83Yi1ZZEpBbHowUjA1S0VpNnJ2NXZnUHRJY09NUDVxZnp2WFNxc1I2Q0x3dTFldXhFNm5JUDR5MlA4a0tDeTUxYm5WYTZMVzZUczJHYjBHbDFFaDRiTDZTSlJNRzFnbHBjNUYwNkR3ejJGa3AweDlpeVdhdk5ucGJmSHctSTdHS3g5N2lMYU1fMDB3TlYtUlBScG4zYUI4bk5LQjVlaGt3blZ5OWRfdkVCY2NFcWYtZ1UxVGxrZWJtZExQSGxFYUN4c1ZSQWhaZkxhT1M1RXRudlNuRXNlMXQ3MzFPMkZTeFRvS3VVaHprWlpsazd1akZOUQ?oc=5","date":"2024-11-06","type":"trial","source":"PR Newswire","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFB1WDU5ck55RW43elc4OXg0VlpSNHlWcEI5NVFYamJwSlJGbzFZZk1HaVhDcl9TbTB6RjE5S3BPVEFRNUdYZERVcVZMRHZYdmtQcHlEZXh3?oc=5","date":"2024-10-06","type":"pipeline","source":"Yahoo Finance UK","summary":"CALIWAY BIOPHARMACEUTICALS CO L (6919.TW) stock price, news, quote and history - Yahoo Finance UK","headline":"CALIWAY BIOPHARMACEUTICALS CO L (6919.TW) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxObHRZbW5qbUhROVktVlZwYWNoYjRlVEtjME5JVzlWRzFqdlhpLXljMk5BWmRqNXZXbmhpTFpHWlR1QmYtbm5WVEJwQ0xfaVFrTnhvRGNNMnkteHpmRGVvTTNYSnRjY3ZFa0QtLXVSX1Q3VFJLOUFtUTRQTTdhX3ZfWHJ5ZlIwRldIT1VpaER0ZndiekZ0akJvOFZPNFlfb21fU1pFQ0pwNVJqdXRNZVRKTDVCQnZJXy1VVWFTQlE0S0ZzVjRKdW1IVWx3WTdJSERaNzk3alM3Zk53Mmd5QWpRcEQzcEdJWVJ0RktSalJXUGRtZk9reGVTbnhkMmo0SlE?oc=5","date":"2024-08-07","type":"pipeline","source":"GlobeNewswire","summary":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire","headline":"Global Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOdlhsdGZaN3Frc1BrU21CeFpJNUEtbjNLcjNucXhJNkZ0RGNpdmpFem40RUpoRG9xU09reWZrOHpRT1h6RUZ0VmJNRFFRMDJITThnbzAxWU82ODJHTmlqV0hNVFk1LTdKVnd5NXQyT3ozVk55TS1YNWtwbGJlZFNUVlA5WFZFTDBSTndRS0lkYjlFU19BMVZ6dERpblBMZHFFTWtrVWtR?oc=5","date":"2024-05-28","type":"patent","source":"BioWorld News","summary":"Celltrion’s Omlyclo gets nod as Europe’s first Xolair biosimilar - BioWorld News","headline":"Celltrion’s Omlyclo gets nod as Europe’s first Xolair biosimilar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE91MnhsUnZnTHREYnRXTllZTU5MS2RvakVLZzU2aWc0VHdXY3VrUm1mUGw2NUFGcTVXaDRVWDBvR0s0MUtNLWlmeWpXQTVkM0dmRmc1Y2hlc1R2Y3J4RGhCUHdUQWNMWGZGaVhzckpaVQ?oc=5","date":"2023-03-13","type":"trial","source":"medwatch.com","summary":"Leo Pharma awaiting final decision on antibody after phase II defeat - medwatch.com","headline":"Leo Pharma awaiting final decision on antibody after phase II defeat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBGQnNmaXZPNThQOWxPNXBRQjFSWFhxSEZXSWU3THBXd2FWOUpPdzlGQkpkYU9VXzBPMDFUbHdVMTZQdHlBMjRNRDFrSjN6cU4xZDFuNjdlZjlBeW9MdzBidHBYRU9EWVo3SGdkWDduTQ?oc=5","date":"2023-01-30","type":"pipeline","source":"medwatch.com","summary":"Leo Pharma to reuse model from failed acquisition - medwatch.com","headline":"Leo Pharma to reuse model from failed acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxOUllaNHdIMHAyb1Q1aklmWTE3ZlI1a0pBaXRaN2lOUnYySGJmTmNlMXRoSnlwcmQ2Q3hrSWJOM1ViYXlraDVkc3drdjZuVS0xeXZnQll0SHF1R016Qm9LLWVVOWVDZHF5M19lVUFjU3BjT2gzU3RfY3ZSVExoWUlCaUl4VUxSX3JzVUdHY041YklsMUNFcmp1clZnbEVyYi1zNGtDc1E0X2Z4WmVjRzc3dzMzcjR3QkZsOVRBUVdkdW1OZTZmY2U1ekZjV3ltYml4YnRobVlUaFppTEtfbGsxT0ZpMzB0OE4xMVBQMkM0UEx0NXJtUE1MbUNfZmpSVFpFbmFQVkUxN0xaNHRGT25UWXJsUFIxSDRIMk5id185S1p2ZmhfczFxRkF4bE9ja1Y1RWNrbkcxRjIwLVdBVGl5cVo2TU5ET0Nqdk55QXJyY3lESlZyNzRv?oc=5","date":"2022-11-22","type":"earnings","source":"PR Newswire UK","summary":"With More than 150+ Molecules in Various Stages of Development, the Atopic Dermatitis Market to Witness Entry of New Drugs - Market Revenue to Cross USD 11 Billion by 2027 - Arizton - PR Newswire UK","headline":"With More than 150+ Molecules in Various Stages of Development, the Atopic Dermatitis Market to Witness Entry of New Dru","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBUNHY2LVR4Sm9DR1NCRjRTV2xfR3VFTU9kQVNzZkE2TlFoLURMV2NnUUp0NFlOZk5kakI1RThTeUN5Wm9yXzJKdmxpODlpTk9MX2lHaHoxS2Q0WEtvaC1v?oc=5","date":"2018-01-15","type":"pipeline","source":"Yahoo Finance Singapore","summary":"TaiMed Biologics Inc. (4147.TWO) interactive stock chart - Yahoo Finance Singapore","headline":"TaiMed Biologics Inc. (4147.TWO) interactive stock chart","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}